Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Russell

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2009
Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trialMatthew R Weir, Fawn Yeh, Angela Silverman, et al.
Current Respiratory Medicine Reviews|March 29, 2016
Outcome Measures for Clinical Trials in Interstitial Lung DiseasesMatthew R Lammi, Robert P Baughman, Surinder S Birring, et al.
American Journal of Respiratory and Critical Care Medicine|September 4, 2014
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosisPhillip L Molyneaux, Michael J Cox, Saffron A G Willis-Owen, et al.
ERJ Open Research|October 26, 2019
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide surveyCatharina C Moor, Marlies S Wijsenbeek, Elisabetta Balestro, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 2025
Racial, Ethnic, Sex, and Gender Equity for Inclusive Interstitial Lung Disease Research: An Official American Thoracic Society Research StatementDeborah Assayag, Ayodeji Adegunsoye, Yet H Khor, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
Journal of Advanced Nursing|September 23, 2021
Impact of COVID-19 and other infectious conditions requiring isolation on the provision of and adaptations to fundamental nursing care in hospital in terms of overall patient experience, care quality, functional ability, and treatment outcomes: systematic reviewRebecca Whear, Rebecca A Abbott, Alison Bethel, et al.
Journal of Clinical Lipidology|June 22, 2010
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) Charlton Wilson, Chun-Chih Huang, Nawar Shara, et al.
The Lancet. Respiratory Medicine|March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE studyR Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
The Lancet. Respiratory Medicine|April 3, 2025
The weight of air: a Commission on palliative care integration in serious respiratory illnessWilliam E Rosa, Afsan Bhadelia, Gemma Bowsher, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2009
Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trialMatthew R Weir, Fawn Yeh, Angela Silverman, et al.
Current Respiratory Medicine Reviews|March 29, 2016
Outcome Measures for Clinical Trials in Interstitial Lung DiseasesMatthew R Lammi, Robert P Baughman, Surinder S Birring, et al.
American Journal of Respiratory and Critical Care Medicine|September 4, 2014
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosisPhillip L Molyneaux, Michael J Cox, Saffron A G Willis-Owen, et al.
ERJ Open Research|October 26, 2019
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide surveyCatharina C Moor, Marlies S Wijsenbeek, Elisabetta Balestro, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 2025
Racial, Ethnic, Sex, and Gender Equity for Inclusive Interstitial Lung Disease Research: An Official American Thoracic Society Research StatementDeborah Assayag, Ayodeji Adegunsoye, Yet H Khor, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
Journal of Advanced Nursing|September 23, 2021
Impact of COVID-19 and other infectious conditions requiring isolation on the provision of and adaptations to fundamental nursing care in hospital in terms of overall patient experience, care quality, functional ability, and treatment outcomes: systematic reviewRebecca Whear, Rebecca A Abbott, Alison Bethel, et al.
Journal of Clinical Lipidology|June 22, 2010
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) Charlton Wilson, Chun-Chih Huang, Nawar Shara, et al.
The Lancet. Respiratory Medicine|March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE studyR Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
The Lancet. Respiratory Medicine|April 3, 2025
The weight of air: a Commission on palliative care integration in serious respiratory illnessWilliam E Rosa, Afsan Bhadelia, Gemma Bowsher, et al.
Pageof 15